Skip to content
Resources > Reports

Generative AI in the Enterprise Software Sector: A Look At Adoption in 2024

Generative artificial intelligence (genAI) has peaked in hype. And as we begin 2024, the reality of existing hurdles on the path to mass adoption of AI in enterprise software begins to set in. Expert Insights in AlphaSense is your single-source solution for superior quality insights on these new developments and market-moving events in the software space.

This whitepaper explores genAI trends in the enterprise software sector in 2024 with premium insights from industry experts.

Download our whitepaper now to read these expert perspectives on the rising adoption of genAI in enterprise software.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.